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AQ3 The utilization of continuous-flow biochemical reactors, including biocatalysis, biotransformation, and biochemical
interaction based flow-analytical systems, and enzyme reactors are recently the focus of attention to produce fine
biochemicals and also show great potential in bioanalytical applications. Continuous-flow biochemical processes
implemented in microstructured reactors enable short development time to production scale utilizing enzymatic
processes to efficiently fulfill the current needs of the fine biochemical and pharmaceutical industry. Immobilization
of the enzymes is preferable because it usually enhances their stability, and in some instances, immobilized enzymes
can even be reused multiple times. In this review on the continuous-flow biochemical reactors, first the enzyme
immobilization strategies will be briefly discussed followed by summarizing the recent developments in the field of
immobilized enzyme microflow reactors for biocatalysis, bioconversion and bioanalytical purposes.
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1. Introduction
AQ4 The utilization of continuous-flow biochemical reactors, includ-
ing bioconversion, biocatalysis, biotransformation, and biochemical
interaction based flow-analytical systems, and continuous-flow
enzyme reactors are gaining high relevance in the production of
specialty fine chemicals, drugs, biotherapeutics, and biofuels
[1, 2]. They also have high potential in bioanalytical applications,
e.g., in genomics, proteomics, metabolomics, and glycomics [3].
Some of the main advantages of enzymatic processes are their high
selectivity, operation under mild conditions (atmospheric pressure,
relatively low temperature comparing to other catalysts), environ-
mental friendliness (biodegradable), and high catalytic efficiency [4].
However, enzyme reactors may suffer from enzyme stability related
issues, emphasizing the need for enzymatic process engineering.
Microreactor technologies and enzyme immobilization are the most
promising avenues for such development [5]. Enzymes immobiliza-
tion is preferable in biochemical reactions because it usually enhan-
ces their stability, and in most instances, immobilized enzymes can
be reusedmultiple times. Based on reusability, the costs of enzymatic
reactions are reduced, extending their applicability in the production
of fine biochemical, biologics, and even biofuels [6]. Enzyme reac-
tors can be scaled down to as little as microfluidic reaction devices,
i.e., microchip-type microreactors (made by microfabrication techni-
ques, e.g., photolithography) or microcapillary devices for continu-
ous-flow productionmode.Microfluidic devices feature large surface
to volume ratios, require only micro- or nanoliter volumes of reagent
solutions, offer high efficiency and repeatability [5], and last but not
the least, scale out option by parallelization. Continuous-flow chem-
ical processing (CFCP) in microfluidic devices is based on a combi-
nation of microunit operations (MUOs) like mixing, reaction,
extraction, etc. During the microreactor design CFCP microchips
are built as a combination of different MUOs [7].
Continuous-flow biochemical processes with conventional reac-
tor systems, like packed bed reactors, had their limitations in mass
and heat transfer [8, 9]. Several articles were published about the
design and optimization of such systems [10–13]. Microreactor
technology could support enzymatic processes to efficiently fulfill
the current needs of rapid process development in the biochemical
and pharmaceutical industry, because microstructured continuous-
flow reactors enable shorter development time to production scale
[14]. Enhancedmass and heat transfer provided by continuous-flow
microreactors can be utilized in process intensification, especially
during multiphase biocatalytic processes. Miniaturization can also
accelerate enzymatic reactions due to decreased diffusion limita-
tion, resulting in reduced production time [15]. Through the scale-
out option, microreactor technology is an option for industrial scale
production, especially for hazardous reactions and/or materials
(e.g., exothermic reactions, high-temperature reactions, reactions
with unstable intermediates) that do not allow conventional reactor
scale up. [16]. Parallel scale-out of microreactors enables high-
throughput operation and can be readily applied to combinatorial
processing [17, 18]. However, despite of all advantages of micro-
fluidic reactors, scale-out (numbering up) by parallelization is still
challenging, because thousands of microreactor units are needed to
reach industrial scale production rate (kg/min) and complex control
systems are required to ensure identical operating conditions in each
unit. On the other hand, conventional scale-up of microreactors by
increasing in channel size risks theirmass and heat transfer efficiency.
The alternative solution is to find an intermediate scale device (e.g., in
millimeter scale) that still ensures enhanced mass and heat transport
rates while increasing production rate by parallelization of a reason-
able number of reactor units [19, 20]. TheAdvanced-Flow™Reactor
system from Corning and the MR-A5™ and MR-A6™ Reactor
systems from Lonza are some of the commercially available solu-
tions applicable for such purposes [21–23].
In this review on continuous-flow biochemical reactors, first,
the major enzyme immobilization strategies will be briefly
discussed, followed by summarizing the recent developments
in the field of immobilized enzyme microflow reactors for
biocatalysis (i.e., enzyme-catalyzed production of fine chemi-
cals, drugs, and biopolymers) and bioanalytical purposes.
2. Enzyme Immobilization Techniques for Continuous-Flow
Operation
Immobilization may cause slight distortions in the enzyme
structure affecting the final properties of the enzyme, namely,
activity, specificity, and selectivity [24, 25]. However, immobi-
lization of enzymes comes with the following advantages: (1)
enhanced stability, (2) option of repeated or continuous use, and* Author for correspondence: a.guttman@neu.edu
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(3) easy partitioning from the reaction mixture [26]. Therefore,
proper enzyme immobilization for continuous-flow operation is
of high importance to increase the efficiency of the enzymatic
reaction. The most fundamental immobilization techniques are
entrapment, adsorption, covalence, affinity, and cross-linking as
depicted in FigureF1 1 [27]. Jones et al. developed an entrapment
method, where enzymes were immobilized by incorporating
them directly into the microchannel material [28]. The so-called
“bioplastic” was prepared by mixing urease enzyme, polydime-
thylsiloxane (PDMS) monomer, and the curing agent. Curing
was accomplished at room temperature to preserve the viability
of the enzyme. The bioplastic contained approximately 0.5–
2.5 wt% urease resulting in a clear, flexible material suitable
for molding into a microreactor device. Adsorption of the
enzymes relies on weak bonds like Van der Waal's or electro-
static interaction. Liu et al. developed a method based on
electrostatic interaction, where the enzyme was immobilized
on a positively charged surface [29]. In the case of covalent
binding (covalence), the supporting material is functionalized
with an active group (e.g., amine, epoxy, etc.) and the enzymes
are covalently bonded to the surface through them [30, 31].
Affinity tags that are present or added at a specific position far
from the active site of the enzyme are capable to form strong
affinity bonds between the enzyme and a surface functionalized
with the complementary affinity ligand. Through the affinity
bond, enzymes could be immobilized by site-specific and ori-
ented manners [32]. As a carrier free immobilization technique,
cross-linked enzyme aggregates (CLEA) recently gained interest
because of their simplicity, great stability, and high activity [33].
These aggregates are usually prepared via glutaraldehyde cross-
linking [34]. Immobilization techniques can also be classified
based on their reaction location. One of the methods is direct
immobilization onto the microchannel wall. Another approach
utilized enzyme immobilization on a solid support inside the
microchannel, e.g., on micro- and nanoparticles [35], porous
polymer monoliths [36, 37] or membranes [38]. Recently, para-
magnetic nanoparticles are also gaining attention because of
their easy manipulation with a permanent magnet [39, 40].
3. Continuous-Flow Biochemical Microreactors for
Biocatalysis and Bioconversion
Microfabricated flow reactor systems with immobilized
enzymes are of great recent importance in the biopharmaceut-
ical industry, namely, in the production of specific antibiotics,
highly toxic antitumor drugs [41, 42], or drug delivery agents
[43]. The main applications of continuous-flow biochemical
microreactor systems utilizing immobilized enzymes for bio-
conversion are summarized in Table T11. The use of enzymatic
processes for bioconversion of common raw materials is con-
tinuously increasing. For example, nitrobenzene is a common
starting material for several dye and drug molecules like phe-
noxazine. Phenoxazine and its derivatives have antitumor activ-
ity because they inhibit the DNA-dependent RNA polymerase
through intercalation into the DNA strands of malignant cells
[44]. Spain and coworkers developed a microfluidics based
multistep chemoenzymatic process for the continuous produc-
tion of 2-aminophenoxazine-3-one from nitrobenzene substrate
[41]. The enzymes of hydroxylaminobenzene mutase and soy-
bean peroxidase were encapsulated in polyethyleneimine medi-
ated silica microparticles and packed in two separate fused
silica capillaries. The complete chemoenzymatic platform was
constructed in a metallic zinc chip and the two serially con-
nected enzyme capillary microreactors, as depicted in Figure F22.
The chemoenzymatic flow-through system ensured rapid con-
version of the nitrobenzene substrate and was also capable of
efficient bioconversion of other nitroarenes.
Cyclodextrins (CDs) with lipophilic inner cavities and hydro-
philic outer surfaces can act as drug delivery vehicles due to
their capability to interact with different drug molecules via
inclusion complexation [45]. An immobilized enzyme micro-
reactor system was developed for the continuous production of
β-cyclodextrin from starch by Schöffer et al. [43]. Cyclodextrin
glycosyltransferase (CGTase) was immobilized on the surface
of glutaraldehyde-activated chitosan spheres, and the micropar-
ticles were packed into a glass tube. The developed immobi-
lized microfluidic enzymatic reactors featured very high
operational stability, and the immobilized CGTase retained its
initial activity even after 100 h of continuous use. In the field of
green chemistry, it is really important to use renewable raw
materials as substrates. Bakonyi and coworkers produced iso-
amyl oleate, a biolubricant, from renewable sources with con-
tinuous enzymatic reaction in a microreactor system (H-Cube™
and X-Cube™ from ThalesNano) [46]. Lipase B was immobi-
lized on an acrylic resin (Novozyme 435), and the enzyme
functionalized resin was packed into the CatCart™ catalyst
cartridge yielding a conversion rate of 98%.
4. Bioanalytical Applications
One of the fastest growing bioanalytical fields these days are
in the so-called omics areas, including genomics, proteomics,
metabolomics, and glycomics. In proteomics, for example, the
key sample preparation step is protein digestion with proteases
such as trypsin, chymotrypsin, etc. [3]. With the use of immo-
bilized enzymes, enzyme-to-substrate ratios can be increased,
speeding up digestion times and reducing autolysis compared to
traditional proteolytic digestion in aqueous solutions. Waldron
and coworkers immobilized chymotrypsin on the wall of a
fused-silica capillary [30]. The resulting immobilized micro-
fluidic enzyme reactor (IMER) produced good results in myo-
globin digestion and 83% sequence coverage was achieved by
capillary electrophoresis–mass spectrometry (CE–MS) peptide
mass mapping following the digestion process. An interesting
enzyme immobilization approach was introduced by Safdar et
al. by fabricating an open tubular flow-microreactor with tryp-
sin immobilized gold nanoparticles attached to the inner wall of
a fused silica capillary [50]. For cytochrome C substrate, the
MS sequence coverage of the resulting peptide mixture was
above 75%. The activity of the immobilized enzyme remained
apparently the same after several repeated digestion steps prov-
ing the high stability of the flow-microreactor even in repeated
Figure 1. Fundamental enzyme immobilization techniques. E: enzyme,
P: inert protein. Reproduced with permission from [26]. ©2012 Elsevier
L. Hajba and A. Guttman
usage. Zhang and coworkers fabricated an immobilized contin-
uous-flow enzyme microreactor using trypsin functionalized
magnetic microparticles [51]. The microflow reactor was
successfully applied for the on-line digestion of the cytochrome
C and BSA. In comparison to solution based digestion, similar
sequence coverages were achieved, but within much shorter
Table 1. Continuous-flow biochemical microreactor systems with immobilized enzymes for bioconversion
Support Immobilization technique Enzyme Applications References
Silica microparticles Enzyme was encapsulated in
polyethyleneimine mediated
silica microparticles packed
into a fused-silica capillary.
Hydroxylaminobenzene
mutase, soybean
peroxidase, nitrobenzene
nitroreductase
Production of antitumor
and antibiotic drugs
[41, 42]
Acrylic resin Enzyme was immobilized on
octadecyl-activated acrylic resin
by hydrophobic interaction.
The microparticles were packed into
a stainless steel tube (CatCart™).
Lipase B
(Novozyme 435)
Biolubricant
production from
renewable raw materials
[46]
Eupergit™ oxirane
acrylic microparticles
Enzyme was immobilized covalently
through the Eupergit epoxy group
without the need for additional
reagents. The microparticles were
packed into a glass tube.
Threonine
aldolase (TA)
Production of
phenylserine
[47]
Chitosan spheres Enzyme was immobilized on the
surface of chitosan spheres with
glutaraldehyde. The microparticles
were packed into a glass tube.
Cyclodextrin
glycosyltransferase
(CGTase)
Production of
β-cyclodextrin
from starch
[43]
Macroporous
wash-coatlayer
of γ-aluminum oxide
The macroporous aluminum oxide layer
on the stainless steel microchannels
was functionalized with APTES,
and the enzyme was cross-linked
to the functionalized surface
with glutaraldehyde.
β-Glycosidase Hydrolysis of lactose [48]
Epoxy-activated
monolithic
Convective Interaction
Media (CIM®) disk
Enzyme was immobilized covalently
through the epoxy group without
the need of any additional reagents.
Glucuronan lyase Production of
oligoglucuronans
[49]
Nylon membrane Hydrochloric acid was used to activate the
amino groups on the membrane surface.
After that, the enzyme was cross-linked
to the membrane surface with glutaraldehyde.
Horseradish peroxidase Production of dyes [38]
Figure 2. Multi-step continuous-flow chemoenzymatic process for the bioconversion of nitrobenzene. Reproduced with permission from Woitalka
et al. (2014) [19]. ©2007 John Wiley and Sons
Figure 3. Schematic representation of a continuous-flow bioanalytical microdevice using glucose peroxidase functionalized magnetic nanoparticles
for amperometric detection of glucose. Reproduced with permission from Miyazaki and Maeda (2006) [18]. ©2012 Elsevier
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processing times. The main advantages of the use of magnetic
nanoparticles were easy manipulation with an external magnetic
field within the microchannel and the trypsin functionalized
magnetic nanoparticles could be easily regenerated. Krenkova
et al. developed an immobilized enzyme flow-microreactor for
rapid and effective release of N-glycans from glycoproteins [52].
The PNGase F enzyme was immobilized on the methacrylate-
based porous monolithic support through GST–glutathione cou-
pling. Most importantly, the oriented PNGase F immobilization
approach they used resulted in significantly higher enzymatic
activity and the immobilized enzyme remained stable for several
months.
Blood glucose is an important marker in diabetes. Ju and
coworkers developed a continuous-flow microfluidic device for
amperometric detection of glucose as shown in FigureF3 3 [40].
Magnetic nanoparticles were functionalized with glucose per-
oxidase, introduced into the capillary of a microfluidic device
and held there by two permanent magnets (magnets were
shorter than the capillary). With increasing enzyme reactor
length (packed length with magnetic nanoparticles), which
was tuned by changing the length of the magnets, the detection
limit improved. The glucose concentration of four human serum
samples determined by the microfluidic device showed good
agreement with spectrophotometric control measurements. The
main bioanalytical applications of immobilized enzyme micro-
reactors are summarized in TableT2 2.
5. Conclusions and Future Perspectives
The utilization of continuous-flow biochemical systems offers
excellent bioprocess intensification and very efficient bioanalytical
tools. Immobilized enzyme microreactors support “green” produc-
tion of biomaterials and pharmaceutical products with excellent
yield and high efficiency. Reaction conditions optimized for a
single microreactor unit can be adapted to larger scale production
by parallelization (scale out); however, this process requires careful
attention of complex control systems that required ensuring identi-
cal operating conditions of the units. New discoveries in nano-
technology and the advent of novel solid support materials such
as carbon nanomaterials advanced enzyme immobilization devel-
opment by allowing higher enzyme load on solid supports. On the
other hand, the microfluidic approach offers great potential for
further development by the utilization of their inherently large
surface to volume ratios. Specific geometric design of the micro-
fluidic channels may also increase the contact efficiency between
the fluid flow and the enzyme containing solid support (e.g., micro-
channel wall, beads, etc.). Enzymemicroreactors will also find their
way in specific biomedical applications as point-of-care microflui-
dic devices for continuous monitoring of disease state.
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